Literature DB >> 7599855

Sepsis trials. Intersection of investigation, regulation, funding, and practice.

G R Bernard1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599855     DOI: 10.1164/ajrccm.152.1.7599855

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

Review 1.  Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium.

Authors:  Y Berthiaume; O Lesur; A Dagenais
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  Antithrombin III and sepsis.

Authors:  E F Mammen
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

Review 3.  Identifying patients with ARDS: time for a different approach.

Authors:  D P Schuster
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

4.  Applying epidemiology-based outcomes research to clinical decision-making. A hypothetical model of biotechnology therapy in gram-negative sepsis.

Authors:  E C Wang; T H Grasela; C A Walawander
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

5.  Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion.

Authors:  L Shapira; W A Soskolne; Y Houri; V Barak; A Halabi; A Stabholz
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

6.  Predicting multiple organ failure in patients with severe trauma.

Authors:  Zeljko Lausevic; Mirjana Lausevic; Jasna Trbojevic-Stankovic; Slobodan Krstic; Biljana Stojimirovic
Journal:  Can J Surg       Date:  2008-04       Impact factor: 2.089

Review 7.  Rational use of computerized protocols in the intensive care unit.

Authors:  A H Morris
Journal:  Crit Care       Date:  2001-09-13       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.